首頁 > 市場調查報告書 > 食物/飲料

食品添加劑

市場調查報告書

商品編碼

1455760

全球異黃酮補充劑市場 - 2023-2030

Global Isoflavone Supplements Market - 2023-2030

出版日期: 2024年03月26日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球異黃酮補充劑市場規模達到7.212億美元，預計2030年將達到107.36萬美元，2023-2030年預測期間CAGR為5.1%。

隨著人們越來越重視天然和植物性產品，消費者正在尋找合成補充劑的替代品。異黃酮是大豆和其他豆類中天然存在的化合物，符合這一趨勢，導致對異黃酮補充劑的需求增加。消費者越來越意識到異黃酮的潛在健康益處，特別是在控制更年期症狀、促進心臟健康以及潛在降低某些癌症的風險方面。

2021年4月，韓國公司Pulmuone推出了一款用於緩解更年期症狀的大豆和啤酒花萃取物補充劑。該公司澄清說，從啤酒花萃取物和黑大豆中提取的異黃酮是有益的，因為它們具有與女性荷爾蒙雌激素的化學結構，雌激素的產生在更年期期間下降並導致更年期症狀。

大豆異黃酮補充劑由於富含金雀異黃酮和大豆黃酮等天然異黃酮，佔據了一半以上的市場。同樣，北美在異黃酮補充劑市場佔據主導地位，由於消費者認知度高、研究基礎設施健全以及對天然健康解決方案日益濃厚的興趣，佔據了最大的市場佔有率。

動力學

更年期症狀的盛行率上升

隨著全球人口老化，越來越多的女性進入更年期。根據美國國家醫學圖書館預測，到 2030 年，全球將有 12 億更年期和停經後女性，其中每年新增 4,700 萬人。隨著越來越多的女性經歷更年期，對有助於控制相關症狀的產品的需求也越來越大。

異黃酮是大豆和其他豆類中發現的植物源性化合物，可模仿體內雌激素的作用，並與緩解這些症狀有關。隨著人們越來越認知到異黃酮補充劑在控制更年期症狀方面的潛在益處，對此類產品的需求也在成長。此外，隨著全球人口老化的加劇，經歷更年期的女性人數不斷增加，進一步推動了市場的擴張。

人們對健康益處的認知不斷增強

異黃酮是天然存在的化合物，主要存在於大豆和其他豆類中。根據國家醫學圖書館的數據，Cancellieri 等人發現，根據 Kupperman 更年期指數，服用含有 72 毫克紅三葉草和大豆異黃酮的草藥補充劑六個月後，潮熱症狀顯著減少。除了緩解更年期症狀外，異黃酮還對骨骼健康具有保護作用，特別是對於骨質疏鬆症風險增加的停經後女性。

異黃酮透過調節骨骼代謝和促進骨形成來幫助維持骨密度並降低骨折風險。此外，人們還研究了異黃酮對心血管的潛在益處，包括透過降低低密度脂蛋白膽固醇水平和增加高密度脂蛋白膽固醇水平來改善血脂狀況的能力。隨著消費者意識到異黃酮補充劑的潛在好處，對這些產品的需求也相應增加。

監管挑戰

監管機構可能會對異黃酮補充劑的行銷和標籤施加限制或指導方針，特別是在健康聲明和安全問題方面。遵守這些法規可能會增加成本並限制製造商推廣其產品的能力，可能會阻礙預測期內的市場擴張。

2020年1月，為了遵守膳食補充劑和嬰兒配方奶粉的通報規定，波蘭首席衛生監察局宣布實施旨在「加強對企業的監管」的通報制度。 2019 年初，波蘭開始對食品補充劑中的物質實施最高限量。在那裡，當局製定了異黃酮（大豆和其他）、蘆薈和 BETA-丙氨酸製劑的使用指南和限制。

With a growing emphasis on natural and plant-based products, consumers are seeking alternatives to synthetic supplements. Isoflavones, which are naturally occurring compounds found in soybeans and other legumes, fit into this trend, leading to increased demand for isoflavone supplements. Consumers are becoming increasingly aware of the potential health benefits associated with isoflavones, particularly in managing menopausal symptoms, promoting heart health, and potentially reducing the risk of certain cancers.

In April 2021, Pulmuone, a South Korean company, launched a soybean and hop extract supplement for alleviating menopausal symptoms. The company clarified that isoflavones derived from hop extracts and black soybeans were beneficial because they had a chemical structure with the female hormone estrogen, whose production declines during menopause and causes menopausal symptoms.

The soy-based isoflavone supplements account for over half of the market share due to their rich content of naturally occurring isoflavones, such as genistein and daidzein. Similarly, North America dominates the isoflavone supplements market, capturing the largest market share due to a combination of high consumer awareness, robust research infrastructure, and a growing interest in natural health solutions.

Dynamics

Rising Prevalence of Menopausal Symptoms

As the global population ages, there is a growing number of women entering menopause. According to the National Library of Medicine, it is predicted that by 2030, there will be 1.2 billion menopausal and postmenopausal women worldwide, with 47 million of them joining the population annually. With a larger population of women experiencing menopause, there is a greater demand for products that can help manage associated symptoms.

Isoflavones, plant-derived compounds found in soy and other legumes, mimic the effects of estrogen in the body and have been associated with alleviating these symptoms. As awareness of the potential benefits of isoflavone supplements in managing menopausal symptoms grows, so does demand for such products. Additionally, with an increasing aging population worldwide, the number of women experiencing menopause is on the rise, further propelling the market expansion.

Growing Awareness about Health Benefits

Isoflavones are naturally occurring compounds found predominantly in soybeans and other legumes. According to the National Library of Medicine, Cancellieri et found that Based on the Kupperman Menopause Index, hot flashes were dramatically reduced after six months of consuming a herbal supplement comprising 72 mg of isoflavones from red clover and soybeans. Along with menopausal symptom relief, isoflavones have a protective effect on bone health, particularly in postmenopausal women who are at increased risk of osteoporosis.

Isoflavones help maintain bone density and reduce the risk of fractures by modulating bone metabolism and promoting bone formation. Also, isoflavones have been studied for their potential cardiovascular benefits, including their ability to improve lipid profiles by reducing LDL cholesterol levels and increasing HDL cholesterol levels. As consumers become aware of the potential benefits of isoflavone supplements, there is a corresponding increase in demand for these products.

Regulatory Challenges

Regulatory agencies may impose restrictions or guidelines on the marketing and labeling of isoflavone supplements, particularly regarding health claims and safety concerns. Compliance with these regulations can increase costs and limit the ability of manufacturers to promote their products, potentially hindering market expansion in the forecast period.

In January 2020, to comply with notification regulations for dietary supplements and infant formulas, Poland's Chief Sanitary Inspectorate announced to implementation a notification system aimed at "improving supervision" of firms. At the beginning of 2019, Poland started imposing maximum amounts on substances found in food supplements. There, authorities established usage guidelines and limitations for isoflavones (soy and other), aloe vera, and beta-alanine preparations.

Segment Analysis

The global isoflavone supplements market is segmented based on source, application, distribution channel and region.

Abundance of Isoflavones in Soybeans

Soybeans are a rich source of isoflavones, a type of phytoestrogen. For instance, about 3.5 mg of isoflavones are linked to every gram of soy protein found in soybeans and conventional soy foods. As a result, roughly 25 mg of isoflavones are present in one serving of classic soy food, such as 100 g of tofu or 250 mL of soymilk. These compounds are known for potential health benefits, including reducing the risk of certain chronic diseases such as heart disease and osteoporosis and alleviating menopausal symptoms. Due to this natural abundance, soy has become a primary ingredient in many isoflavone supplements.

In October 2023, Pharmalinea introduced an advanced whole-body menopause supplement. According to Maja Oresnik, Science & Research Director, the new supplement contains Soy isoflavones (Qsoy), resveratrol (Qratrol), and vitamin B6, which has been clinically demonstrated to affect phytoestrogen activity, improve cerebral blood flow and vasodilation, enhance insulin sensitivity and cognitive function, slow down the loss of bone mineral density, and lessen chronic pain.

Geographical Penetration

Growing Awareness about Isoflavone Supplements in North America

There is a growing awareness and interest among consumers in North America regarding the health benefits of isoflavones, particularly in managing conditions such as menopausal symptoms and promoting heart health. According to the National Library of Medicine, every year, about 1.3 million women in the US experience menopause. Isoflavone supplements are often utilized to alleviate menopausal symptoms, providing relief to women experiencing discomfort during this transitional phase of life.

Additionally, North America boasts a well-established dietary supplement industry supported by robust distribution channels and widespread availability of various health products, including isoflavone supplements. The accessibility of these supplements through pharmacies, health food stores, online retailers, and other outlets further contributes to the market's dominance in the region.

COVID-19 Impact Analysis

The COVID-19 pandemic led to widespread disruptions in global supply chains, affecting the production and distribution of various goods, including dietary supplements. Restrictions on movement, lockdown measures, and workforce shortages disrupted the supply of raw materials and manufacturing processes for isoflavone supplements. This resulted in delays in production, shortages in supply, and increased costs for manufacturers, impacting the availability of isoflavone supplements in the market.

However, the pandemic prompted a shift in consumer priorities towards health and wellness. With heightened awareness of immune health and overall well-being, there was increased interest in dietary supplements, including those containing isoflavones. Consumers sought products that could potentially support their immune systems and help manage stress and anxiety during uncertain times. This shift in consumer behavior led to a surge in demand for isoflavone supplements, particularly those marketed for their potential health benefits.

Russia-Ukraine War Impact Analysis

The conflict between Russia and Ukraine disrupted global supply chains, affecting the transportation of goods and raw materials. Ukraine is a significant producer of soybeans, a primary source of isoflavones used in supplements. The disruptions in soybean production and export from Ukraine led to shortages or delays in the availability of raw materials for isoflavone supplements, thereby affecting the supply chain and potentially leading to price fluctuations in the market.

By Source

Soy
Chickpea
Red Clover
Others

By Application

Food & Beverage
Cosmetics
Nutraceuticals
Pharmaceuticals
Others

By Distribution Channel

Hypermarkets/Supermarkets
Drug Stores & Pharmacies
E-Commerce
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In October 2023, Nutravita, a supplement company, released a new line to help women through the menopausal phase of life with a choice of supplements that successfully address the most prevalent symptoms in honor of 'Menopause Awareness Month'. It contains soy isoflavones, which are phytoestrogen chemicals and a natural substitute for hormone replacement treatment, in addition to essential minerals that support menopause.
In February 2023, Pro360, the nutraceutical brand of GMN Group of Companies, launched the FemCare+ and HPHF (High Protein High Fibre) product lines. These products are designed to provide both men and women with a variety of advantages to enhance their lifestyles. Among the enriched, natural ingredients used in the FemCare+ collection are Shatavari, Myo-Inositol, Black Cohosh, Evening Primrose, and Soy Isoflavones.
In November 2021, Otsuka Pharmaceutical Co., Ltd., launched tocoelle, a supplement to support women bothered by pre-menstrual fluctuations. It provides four essential elements: calcium, which is frequently deficient in daily diets; equol, which is made from soy isoflavones; and vitamin E (Y-tocopherol and Y-tocotrienol), which is found in soy oil.
In March 2023, Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced the launch of launch of a new version of EQUELLE gelee, an extension of the EQUELLE brand of supplements promoting women's health and beauty. It has 3.2 mg of soy isoflavones (aglycone), 2,500 mg of collagen peptides, and 5 mg of S-equol.

Competitive Landscape

The major global players in the market include NOW Health Group, Inc., Solgar Inc., Swanson, Life Extension, GNC Holdings, LLC, Pure Encapsulations, Bluebonnet Nutrition, Douglas Laboratories, Jabs Biotech Pvt. Ltd., 21ST Century HealthCare, Inc.

Why Purchase the Report?

To visualize the global isoflavone supplements market segmentation based on source, application, distribution channel, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of isoflavone supplements at the market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global isoflavone supplements market report would provide approximately 62 tables, 56 figures, and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Source
3.2.Snippet by Application
3.3.Snippet by Distribution Channel
3.4.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Rising Prevalence of Menopausal Symptoms
  - 4.1.1.2.Growing Awareness about Health Benefits
- 4.1.2.Restraints
  - 4.1.2.1.Regulatory Challenges
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis
5.5.Russia-Ukraine War Impact Analysis
5.6.DMI Opinion

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Source

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2.Market Attractiveness Index, By Source
7.2.Soy*
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Chickpea
7.4.Red Clover
7.5.Others

8.By Application

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2.Food & Beverage*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Cosmetics
8.4.Nutraceuticals
8.5.Pharmaceuticals
8.6.Others

9.By Distribution Channel

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2.Market Attractiveness Index, By Distribution Channel
9.2.Hypermarkets/Supermarkets*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Drug Stores & Pharmacies
9.4.E-Commerce
9.5.Others

10.By Region

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2.Market Attractiveness Index, By Region
10.2.North America
- 10.2.1.Introduction
- 10.2.2.Key Region-Specific Dynamics
- 10.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1.U.S.
  - 10.2.6.2.Canada
  - 10.2.6.3.Mexico
10.3.Europe
- 10.3.1.Introduction
- 10.3.2.Key Region-Specific Dynamics
- 10.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1.Germany
  - 10.3.6.2.UK
  - 10.3.6.3.France
  - 10.3.6.4.Italy
  - 10.3.6.5.Russia
  - 10.3.6.6.Rest of Europe
10.4.South America
- 10.4.1.Introduction
- 10.4.2.Key Region-Specific Dynamics
- 10.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1.Brazil
  - 10.4.6.2.Argentina
  - 10.4.6.3.Rest of South America
10.5.Asia-Pacific
- 10.5.1.Introduction
- 10.5.2.Key Region-Specific Dynamics
- 10.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1.China
  - 10.5.6.2.India
  - 10.5.6.3.Japan
  - 10.5.6.4.Australia
  - 10.5.6.5.Rest of Asia-Pacific
10.6.Middle East and Africa
- 10.6.1.Introduction
- 10.6.2.Key Region-Specific Dynamics
- 10.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11.Competitive Landscape

11.1.Competitive Scenario
11.2.Market Positioning/Share Analysis
11.3.Mergers and Acquisitions Analysis

12.Company Profiles

12.1.NOW Health Group, Inc.*
- 12.1.1.Company Overview
- 12.1.2.Product Portfolio and Description
- 12.1.3.Financial Overview
- 12.1.4.Key Developments
12.2.Solgar Inc.
12.3.Swanson
12.4.Life Extension
12.5.GNC Holdings, LLC
12.6.Pure Encapsulations
12.7.Bluebonnet Nutrition
12.8.Douglas Laboratories
12.9.Jabs Biotech Pvt. Ltd.
12.10.21ST Century HealthCare, Inc.

LIST NOT EXHAUSTIVE

13.Appendix

13.1.About Us and Services
13.2.Contact Us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

異黃酮市場規模：按來源[大豆（飲料、膳食補充劑、化妝品）、鷹嘴豆（飲料、膳食補充劑、化妝品）、紅三葉草（飲料、膳食補充劑、化妝品）]及2023～2032年預測

FAQ

全球異黃酮補充劑市場 - 2023-2030

Global Isoflavone Supplements Market - 2023-2030

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

第 5 章：產業分析

第 6 章：COVID-19 分析

第 7 章：按來源

第 8 章：按應用

第 9 章：按配銷通路

第 10 章：按地區

第 11 章：競爭格局

第 12 章：公司簡介

第 13 章：附錄